Last reviewed · How we verify
NCT03471403: COPDA
Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
trial in Familial Adenomatous Polyposis in 100 participants. Currently enrolling.
10 October 2027
Quick facts
| Lead sponsor | Western Sydney Local Health District |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 10 October 2017 |
| Primary completion | 10 October 2027 |
| Estimated completion | 10 October 2028 |
| Sites | 1 location across Australia |
Conditions studied
- Familial Adenomatous Polyposis — all drugs for Familial Adenomatous Polyposis →
Sponsor
Western Sydney Local Health District — full company profile →
Who can join
Adults 18 to 99, any sex, with Familial Adenomatous Polyposis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to collect prospective observational data regarding patients with diagnosed Familial Adenomatous Polyposis (FAP) undergoing cold snare polypectomy for duodenal adenomas
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03471403
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Familial Adenomatous Polyposis
Currently open trials in the same condition.
- NCT06557733 — An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis · Phase 2 · recruiting
- NCT05630794 — Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 · Phase 1 · recruiting
- NCT06538402 — Ten Versus Fifteen Centimeter Pouch in IPAA Surgery · NA · recruiting
- NCT06614738 — Microbial and Environmental Factors Associated with Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironm · recruiting
- NCT06545526 — Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis · Phase 3 · recruiting
Other Western Sydney Local Health District trials
Trials by the same sponsor.
- NCT07445334 — Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes · NA · not yet recruiting
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06365411 — GEnomic Medicine in Kidney Transplantation Study · not yet recruiting
- NCT06828562 — GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study · enrolling by invitation
- NCT05509153 — A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03471403 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Western Sydney Local Health District
- Last refreshed: 27 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03471403.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing